CBD watchdog Leafreport tests sleeping products, with eye-opening results

The need to improve sleep is one of the main reasons why US consumers buy CBD, according to CBD-Intel’s latest market research. However, a recent report from a CBD watchdog claims that 60% of the CBD products marketed as sleep aids do not contain the amounts of CBD, cannabinol (CBN) and/or melatonin stated on the product labels.

The CBD website, Leafreport, bought 52 cannabinoid-containing sleep aids – mostly in the form of gummies, tinctures or capsules – and sent them to an accredited third-party cannabis lab to test the amounts of CBD, CBN and melatonin the products contained against the amounts listed on their labels.

Read full article
I'm already a subscriber
Author default picture

Lorraine Mullaney

Senior writer
Lorraine is responsible for writing news analysis and assisting with copy-editing. Lorraine is a copywriter and editor who has written and edited words for a wide range of audiences, from local community newspapers to consumer magazines and trade websites.

Our Key Benefits

The global cannabis market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

CannIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization